![]() FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. | ![]() Melinta Therapeutics Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
| ![]() GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ||
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2000 | Founding Date 2012 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations San Carlos, US HQ | Locations Watertown, US HQ | Locations Morristown, US HQ New Haven, US | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB |
Employees | Employees 462% decrease | Employees 77 | Employees 1712% increase | Employees 352106% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 998.7 m | Valuation ($) N/A | Valuation ($) 4.4 b |
Financial | ||||
Net income | Net income N/A | Net income ($173m) (FY, 2021) | Net income N/A | Net income ($303.1m) (FY, 2021) |
Funding | ||||
Latest funding round | Latest funding round $ 37.5m (over 11 years ago) | Latest funding round N/A | Latest funding round $ 123.2m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 41m | Total funding raised $ 142.5m | Total funding raised $ 519.2m | Total funding raised $ 88.7m |

FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.
View company
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
View company
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company